Literature DB >> 7588399

Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase.

E Schulze1, G Scharer, A Rogatzki, L Priebe, S Lewicka, M Bettendorf, W Hoepffner, U E Heinrich, U Schwabe.   

Abstract

We studied 95 patients and their relatives with the classical salt wasting (SW) and simple virilizing (SV) form of CAH. SSCP/heteroduplex analysis allowed fast and efficient screening for the most common 21-hydroxylase mutations (e.g. deletions, splice site mutation in intron 2 (bp 656), Ile172Asn mutation in exon 4) and determination of the relative intensities of CYP21A and CYP21B genes. The splice site mutation in intron 2 was found as the most frequent cause of 21-hydroxylase deficiency (35% of our patients). There is a strong genetic association between the mutation in intron 2 and the SW form of CAH. On the other hand, about 20% of our patients with the intron 2 mutation have the SV phenotype. Interestingly, homozygous splice site mutations in intron 2 were also detected in some parents or other relatives with no phenotypic changes typical for CAH (clinical evaluation, steroid hormone levels). In those patients with SV-CAH and especially in the relatives with the homozygous intron 2 mutation and an unaffected phenotype, the splice site mutation could be "leaky". mRNA-splicing in the adrenal cortex should result in a high degree of normal mRNA species. This is in contrast to in vitro expression studies of CYP21B genes containing the intron 2 mutation, performed by other groups. However, the results of in vitro expression studies are not always reflecting the in vivo conditions in the adrenal cortex. This situation is in good agreement with the variable degree of normal spliced mRNA and different phenotypic severity in intron mutations found in thalassemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588399     DOI: 10.3109/07435809509030452

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  9 in total

1.  Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene.

Authors:  A Bobba; A Iolascon; S Giannattasio; M Albrizio; A Sinisi; F Prisco; F Schettini; E Marra
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Non-expression of a common mutation in the 21-hydroxylase gene: implications for prenatal diagnosis and carrier testing.

Authors:  G Rumsby; A F Massoud; C Avey; C G Brook
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

3.  Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  Dianne Keen-Kim; Joy B Redman; Reno U Alanes; Michele M Eachus; Robert C Wilson; Maria I New; Jon M Nakamoto; Raymond G Fenwick
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

4.  Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles.

Authors:  Klaus Prank; Egbert Schulze; Olaf Eckert; Tim W Nattkemper; Markus Bettendorf; Christiane Maser-Gluth; Terrence J Sejnowski; Arno Grote; Erika Penner; Alexander von Zur Mühlen; Georg Brabant
Journal:  Eur J Endocrinol       Date:  2005-08       Impact factor: 6.664

5.  CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Authors:  Firdevs Baş; Hülya Kayserili; Feyza Darendeliler; Oya Uyguner; Hülya Günöz; Memnune Yüksel Apak; Fatmahan Atalar; Rüveyde Bundak; Robert C Wilson; Maria I New; Bernd Wollnik; Nurçin Saka
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-02-02

6.  Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center.

Authors:  Yangho Yoo; Mi Sun Chang; Jieun Lee; Sung Yoon Cho; Sung Won Park; Dong-Kyu Jin; Hyung-Doo Park
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-09-30

Review 7.  Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Mirjana Kocova; Violeta Anastasovska; Henrik Falhammar
Journal:  Endocrine       Date:  2020-05-05       Impact factor: 3.633

Review 8.  Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Mirjana Kocova; Paola Concolino; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

9.  Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population.

Authors:  R A A Mahmoud; N H Amr; N N Toaima; T M Kamal; H H Elsedfy
Journal:  J Endocrinol Invest       Date:  2021-08-02       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.